Invesco NASDAQ Biotechnology ETF
IBBQ
40 hedge funds and large institutions have $21.7M invested in Invesco NASDAQ Biotechnology ETF in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 6 closing their positions.
167% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 6
25% more funds holding
Funds holding: 32 → 40 (+8)
16% more capital inflows, than outflows
Capital inflows: $11.6M | Capital outflows: $10M
2.97% less ownership
Funds ownership: 32.63% → 29.66% (-3%)
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$3.2M |
| 2 |
LPL Financial
San Diego,
California
|
+$3.16M |
| 3 |
Clearstead Advisors
Cleveland,
Ohio
|
+$1.13M |
| 4 |
Tower Research Capital (TRC)
New York
|
+$967K |
| 5 |
Jane Street
New York
|
+$943K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$6.13M |
| 2 |
WMS Group
Folsom,
Louisiana
|
-$2.63M |
| 3 |
Raymond James Financial
St Petersburg,
Florida
|
-$368K |
| 4 |
Partners Capital Investment Group
Boston,
Massachusetts
|
-$367K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$226K |
IBBQ Hedge Fund Activity: Q1 2026 in Review
40 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q1 2026, worth a combined $21.7M — up 6.3% from $20.4M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new IBBQ positions and 6 closed out — a net gain of 10 holders — while 7 added to existing stakes and 9 trimmed.
The largest buyer was Commonwealth Equity Services, opening a new position worth an estimated $3.2M. The largest seller was Mirae Asset Global Investments, exiting entirely with an estimated $6.13M sold.
- 40 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q1 2026, up from 32 in Q4 2025.
- Funds reported $21.7M of Invesco NASDAQ Biotechnology ETF stock for Q1 2026, up 6.3% quarter-over-quarter.
- 16 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q1 2026 and 6 closed out, a net change of +10 holders.
- The largest Invesco NASDAQ Biotechnology ETF buyer in Q1 2026 was Commonwealth Equity Services, an estimated $3.2M added.
- The largest Invesco NASDAQ Biotechnology ETF seller in Q1 2026 was Mirae Asset Global Investments, an estimated $6.13M sold.
Based on aggregated 13F filings for Q1 2026.